Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$35.75 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 215.00M 147.47M 92.68M 12.02M
Cost of Sales 9.07M 6.75M 2.74M 1.10M
Gross Operating Profit 205.94M 140.71M 89.94M 10.91M
Selling, General, and Administrative Expenses 106.01M 89.06M 72.61M 55.59M
Research & Development 42.79M 29.14M 19.59M 17.25M
Operating Income before D & A (EBITDA) 57.13M 22.51M -2.26M -61.92M
Depreciation & Amortization 2.92M 1.67M 3.02M 3.77M
Interest Income 1.48M 643.00K 348.00K 299.00K
Other Income - Net -238.00K -2.11M 256.00K -22.80M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 55.46M 19.38M -4.67M -88.20M
Interest Expense 5.09M 4.77M 5.62M 7.85M
Pre-Tax Income 50.37M 14.61M -10.29M -96.05M
Income Taxes -40.85M 666.00K 630.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 91.22M 13.94M -10.93M -92.27M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 91.22M 13.94M -10.93M -92.27M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 91.22M 13.94M -10.93M -92.27M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
91.22M 13.94M -10.93M -92.27M
Preferred Dividends
Net Income Available To Common 91.22M 13.94M -10.93M -92.27M
Basic EPS from Continuing Ops. 1.84 0.29 -0.26 -2.90
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.84 0.29 -0.26 -2.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.84 0.29 -0.26 -2.90
Basic Normalized Net Income/Share 1.84 0.29 -0.26 -2.90
EPS fr Continuing Ops. 1.76 0.28 -0.26 -2.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.76 0.28 -0.26 -2.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.76 0.28 -0.26 -2.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.76 0.28 -0.26 -2.90
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases

Partner Headlines for SUPN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter